Yes, that is him. Also an interesting coincidence (though probably nothing) is that Paul Rennert of Sugarcone Biotech Blog showed an initial interest in Bavituximab on March 2 in his very thorough piece outlining the immunotherapy landscape. We know what happened 3 days later. Today, he is again trumpeting the PS technology having viewed some of the data at AACR. In his words on twitter, "Impressive really". It's always good to keep tabs on sudden changes of heart relating to PS when they come from people who link Chimera research on their home page. Just something to follow.
CP, I am really mad at myself for not attending NYAS in person. I changed my mind at the last minute. Something tells me I would have met several people that I hold in high esteem. One of which is a valued poster on this board :)
I replied about Scott twice and was deleted. This post is about PPHM so please don't delete. I personally asked Scott to write an article about PPHM last year at this time. I gave him all my personal info cell etc. so we could talk. He said Bavi is too good to be true and he did not like the 4 person board. He told me he may write an article if they actually were able to start a phase III. So I took it upon myself to write some articles on SA.
Well Peregrine started their phase III and Scott is here. He has ALOT of followers me included. I want to know his agenda?
Why bash what may be the greatest discovery in medicine?
Market Data 
Markets 
AI
